“DTx will be supportive in driving healthcare outcomes for our lifetime,” Hanaman concluded. Click Therapeutics' digital therapeutic (DTx) for migraine prevention has been cleared by the ...

Click Therapeutics' digital therapeutic (DTx) CT-132 has been approved by the FDA, becoming the first treatment of its type in the US for preventing attacks in people with episodic migraine.

Emerging technologies not only expedite the development of new drugs, but also introduce a completely new class of therapies, such as digital therapeutics (DTx), which are software-based solutions ...

The company will spotlight its latest advancements, including: RESET® and RESET-O®—the first and only FDA-authorized digital therapeutics for SUD and opioid use disorder (OUD). Watch the video ...

The FDA has granted marketing authorization to CT-132 for the preventive treatment of episodic migraine in patients aged 18 years and older.

CHICAGO — More patients with heart failure achieved target medical doses with remote titration with digital therapeutics vs. usual care, with better efficacy among older vs. younger patients.

PursueCare, a leading provider of virtual addiction treatment and specialized pharmacy services, is proud to announce its participation in the 56th Annual American Society of Addiction Medicine ...

Mario Aguilar covers technology in health care, including artificial intelligence, virtual reality, wearable devices, telehealth, and digital therapeutics. His stories explore how tech is changing ...